Compare SPDR Gold Trust (GLD) vs Illumina, Inc. (ILMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SPDR Gold Trust vs Illumina, Inc. — how do they compare? SPDR Gold Trust trades at $383.34 (market cap $139.66B), while Illumina, Inc. trades at $265 (market cap $39.95B). The key difference: SPDR Gold Trust is far larger — about 3.5× Illumina, Inc.'s market cap, and Illumina, Inc. is trading nearer its 52-week high, SPDR Gold Trust nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold SPDR Gold Trust for 74 Days and Illumina, Inc. for 83 Days on average.
| GLD | ILMN | |
|---|---|---|
Market Cap | $139.66B | $39.95B |
Volume | 9,544,773 | 3,169,503 |
52-Week High | $495.90 | $293.69 |
52-Week Low | $362.32 | $91.00 |
Typical Hold Time | 74 Days | 83 Days |
Sector | — | Health |
Enterprise Value | — | $41.31B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GLD is trading at $375.88, down 1.66% over the past 24 hours amid broader market pressure from rising Treasury yields and Federal Reserve policy uncertainty. The technical picture remains bearish with moving averages and oscillators signaling continued downward momentum, while key support levels cluster around $372-375. Recent news highlights gold's struggle to maintain gains despite weak economic data, with prices testing critical support zones.
The outlook for GLD remains challenged by persistent headwinds from elevated yields and dollar strength, though some analysts see tactical buying opportunities at current levels. Key risks include further Fed tightening and deteriorating technical momentum, while potential catalysts include sustained inflation concerns and geopolitical tensions that could revive safe-haven demand.
Illumina (ILMN) trades at $267.76, down 2.11% on the day but remains near its 52-week high. The stock exhibits a bullish technical trend with strong moving average signals, while recent earnings beats and a significant return to profitability in 2025 highlight fundamental improvement. Positive sentiment is fueled by S&P 500 inclusion and analyst upgrades, though high valuation ratios present a risk.
The outlook is cautiously optimistic, driven by sequencing growth and AI initiatives, but investors face risks from elevated valuations, competitive pressures, and potential margin volatility. The consensus price target of $241 suggests near-term downside from current levels despite a majority of analysts maintaining a Buy rating.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SPDR Gold Trust
GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →
